MarketAnalysisMarketAnalysis
NASDAQ:MRNA

Moderna, Inc. - NASDAQ:MRNA - Comprehensive analysis

Free evaluation through quantitative algorithms Moderna, Inc. - NASDAQ:MRNA

Quant Rating

1

Strong Sell

2

Sell

3

Hold

4

Buy

5

Strong Buy


The overall quant rating is not an average of the factor grades listed.Instead, it gives greater weight to the metrics with the strongest predictive value.

Growth-Scoring Model Detail

Name

Fatcor
Percentage

Total Revenue Growth Over Prior Year

-52.75

Market

1

Sector

5

Gross Profit Growth Over Prior Year

0

Market

0

Sector

0

EBITDA Growth Over Prior Year

0

Market

0

Sector

0

EBITA Growth Over Prior Year

0

Market

0

Sector

0

EBIT Growth Over Prior Year

0

Market

0

Sector

0

Earnings from Cont. Ops. Growth Over Prior Year

0

Market

0

Sector

0

Net Income Growth Over Prior Year

0

Market

0

Sector

0

Normalized Net Income Growth Over Prior Year

0

Market

0

Sector

0

Diluted EPS before Extra Growth Over Prior Year

0

Market

0

Sector

0

A/R Growth Over Prior Year

-59.87

Market

1

Sector

5

Inventory Growth Over Prior Year

-42.08

Market

1

Sector

2

PPE Net Growth Over Prior Year

11.17

Market

81

Sector

79

Total Assets Growth Over Prior Year

-23.25

Market

2

Sector

18

Tangible Book Value Growth Over Prior Year

-21.43

Market

8

Sector

31

Common Equity Growth Over Prior Year

-21.32

Market

6

Sector

30

Cash from Ops. Growth Over Prior Year

0

Market

0

Sector

0

CAPEX Growth Over Prior Year

48.7

Market

94

Sector

85

Dividend per Share Growth Over Prior Year

0

Market

36

Sector

48

Levered Free Cash Flow Growth Over Prior Year

0

Market

0

Sector

0

Unlevered Free Cash Flow Growth Over Prior Year

0

Market

0

Sector

0

Profitability-Scoring Model Detail

Name

Fatcor
Percentage

Gross Margin %

-85.63

Market

1

Sector

2

SG&A Margin %

36.3

Market

89

Sector

47

EBITDA Margin %

-116.07

Market

1

Sector

6

EBITA Margin %

-121.91

Market

1

Sector

6

EBIT Margin %

-121.91

Market

1

Sector

7

Earnings from Cont. Ops Margin %

-110.04

Market

1

Sector

8

Net Income Margin %

-110.04

Market

1

Sector

8

Net Income Avail. for Common Margin %

-110.04

Market

1

Sector

8

Normalized Net Income Margin %

-68.58

Market

1

Sector

10

Levered Free Cash Flow Margin %

-95.41

Market

1

Sector

10

Unlevered Free Cash Flow Margin %

-94.95

Market

1

Sector

10

Return on Assets %

-15.14

Market

1

Sector

48

Return on Capital %

-18.44

Market

1

Sector

48

Return on Equity %

-28.77

Market

2

Sector

56

Return on Common Equity %

-28.77

Market

2

Sector

56

Total Asset Turnover

0.2

Market

18

Sector

42

Sub-Scoring Model

Valuation
Momentum
Growth
Profitability
80
60
40
20
Valuation: 91
Momentum: 3
Growth: 26
Profitability: 7

Valuation-Scoring Model Detail

Name

Fatcor
Percentage

TEV/LTM Total Revenue

0.64

Market

6

Sector

14

TEV/LTM EBITDA

0

Market

0

Sector

0

P/LTM Normalized EPS

0

Market

0

Sector

0

P/BV

1.04

Market

6

Sector

35

TEV/LTM Unlevered FCF

0

Market

0

Sector

0

Momentum-Scoring Model Detail

Name

Fatcor
Percentage

1M Price Performance

-22.64

Market

3

Sector

29

3M Price Performance

-23.81

Market

10

Sector

51

6M Price Performance

-52.87

Market

1

Sector

26

9M Price Performance

-77.95

Market

1

Sector

17

1Y Price Performance

-74.97

Market

1

Sector

24

Start analyzing Moderna, Inc. - NASDAQ:MRNA with easy-to-understand research reports

Start analyzing Recent popular companies with easy-to-understand research reports